The polyhydroxy acid gluconolactone protects against ultraviolet radiation in an in vitro model of cutaneous photoaging.
Ultraviolet (UV) radiation damages skin through a variety of mechanisms, including the generation of free radicals. Gluconolactone is a polyhydroxy acid (PHA) that is capable of chelating metals and may also function by scavenging free radicals, thereby protecting skin from some of the damaging effects of UV radiation. This study measured the ability of gluconolactone to protect against UV radiation-induced damage. The ability of gluconolactone to prevent UV radiation-induced elastin promoter activation was determined in vitro using a transgenic model of cutaneous photoaging. Gluconolactone was also evaluated to determine its ability to promote the formation of sunburn cells in human skin after exposure to UV radiation. Gluconolactone provided up to 50% protection against UV radiation, as measured in our in vitro system, and did not significantly increase sunburn cells in human skin. These results demonstrate the ability of the PHA gluconolactone to protect against UV radiation-induced elastin promoter activation. In addition, in vivo studies demonstrated that gluconolactone treatment does not result in a significant increase in sunburn cells. Further investigation of this and other PHAs is necessary to identify their potential role in preventing and repairing cutaneous photodamage.